Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Koehler

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Cancer Medicine|March 19, 2020
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practiceSameer A Parikh, Sara J Achenbach, Timothy G Call, et al.
American Journal of Hematology|March 22, 2021
The prognostic significance of del6q23 in chronic lymphocytic leukemiaHadiyah Y Audil, Paul J Hampel, Daniel L Van Dyke, et al.
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
American Journal of Hematology|October 26, 2021
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosisEli Muchtar, Amber B Koehler, Michael J Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2024
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolismAmber B Koehler, Kari G Rabe, Daniel J Crusan, et al.
Leukemia & Lymphoma|June 25, 2026
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general populationLauren D Pomerantz, Kari G Rabe, Paul J Hampel, et al.
Annals of Hematology|April 4, 2018
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemiaJonas Paludo, Jithma P Abeykoon, Amanda Shreders, et al.
Blood Cancer Journal|January 7, 2026
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experienceDomitilla Baccon, Suheil Albert Atallah-Yunes, Paul J Hampel, et al.
Leukemia|December 10, 2024
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy eraPaul J Hampel, Kari G Rabe, Yucai Wang, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Cancer Medicine|March 19, 2020
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practiceSameer A Parikh, Sara J Achenbach, Timothy G Call, et al.
American Journal of Hematology|March 22, 2021
The prognostic significance of del6q23 in chronic lymphocytic leukemiaHadiyah Y Audil, Paul J Hampel, Daniel L Van Dyke, et al.
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
American Journal of Hematology|October 26, 2021
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosisEli Muchtar, Amber B Koehler, Michael J Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2024
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolismAmber B Koehler, Kari G Rabe, Daniel J Crusan, et al.
Leukemia & Lymphoma|June 25, 2026
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general populationLauren D Pomerantz, Kari G Rabe, Paul J Hampel, et al.
Annals of Hematology|April 4, 2018
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemiaJonas Paludo, Jithma P Abeykoon, Amanda Shreders, et al.
Blood Cancer Journal|January 7, 2026
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experienceDomitilla Baccon, Suheil Albert Atallah-Yunes, Paul J Hampel, et al.
Leukemia|December 10, 2024
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy eraPaul J Hampel, Kari G Rabe, Yucai Wang, et al.
Pageof 10